Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Document › Details

Faron Pharmaceuticals Oy. (2/28/17). "Press Release: Proposed Placing and Subscription to Raise Up to £5.0 Million [Not for United States, Australia, Canada, Japan, et al.]". Turku.

Organisations Organisation Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON)
  Organisation 2 Panmure Gordon (UK) Ltd.
  Group Panmure Gordon (Group)
Products Product Clevegen
  Product 2 investment banking
Index term Index term Faron Pharmaceuticals–SEVERAL: investment, 201702–201703 capital increase £5m w placing of 1.36m + subscription of 60k shares at350p/share
Persons Person Jalkanen, Markku (Faron Pharmaceuticals 201505 CEO)
  Person 2 Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications)

Record changed: 2023-06-05


Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px

» top